Literature DB >> 7492615

Alkaline sphingomyelinase activity in rat gastrointestinal tract: distribution and characteristics.

R D Duan1, L Nyberg, A Nilsson.   

Abstract

Previous studies indicated that there was an alkaline sphingomyelinase (SMase) activity in small intestine, but its properties have not been studied in detail. In the present work, we studied the distribution of this enzyme activity in rat gastrointestinal tract and characterized it in intestinal mucosal homogenates. Little alkaline SMase activity was detected in the stomach and the duodenum. The activity in both mucosa and intestinal content increased in the small intestine and reached the maximum at the distal jejunum, then declined in the ileum and slightly increased again in the colon. The activity distribution pattern differed markedly from those of acid SMase and alkaline phosphatase. Little alkaline SMase activity could be found in bile, liver and pancreas before or after treatment with trypsin. The optimum pH of the alkaline SMase was 9. It specifically hydrolyzed sphingomyelin (SM), not phosphatidylcholine, to ceramide and phosphocholine. The alkaline SMase was bile salt dependent and was optionally activated by 3 mM bile salts. Triton X-100 could not mimic the effect of bile salt, rather dose-dependently inhibited the enzyme activity. Ca2+, Mg2+ did not change the alkaline SMase activity in the presence of bile salts, and reduced the activity in the absence of bile salt. Trypsin inactivated acid SMase in pancreas, liver and duodenum but had no influence on intestinal alkaline SMase activity. In conclusion, the intestinal alkaline SMase has a specific distribution pattern and the characters of it differ in several respects from the known acid and neutral SMases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492615     DOI: 10.1016/0005-2760(95)00137-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  Role of the gut in modulating lipoprotein metabolism.

Authors:  Alan A Hennessy; R Paul Ross; Gerald F Fitzgerald; Noel Caplice; Catherine Stanton
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

2.  Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity.

Authors:  Jun Wu; Ake Nilsson; Bo A G Jönsson; Hanna Stenstad; William Agace; Yajun Cheng; Rui-Dong Duan
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

3.  Evidence for specific ceramidase present in the intestinal contents of rats and humans.

Authors:  R D Duan; Y Cheng; L Yang; L Ohlsson; A Nilsson
Journal:  Lipids       Date:  2001-08       Impact factor: 1.880

4.  Digestion of Ceramide 2-Aminoethylphosphonate, a Sphingolipid from the Jumbo Flying Squid Dosidicus gigas, in Mice.

Authors:  Nami Tomonaga; Yuki Manabe; Tatsuya Sugawara
Journal:  Lipids       Date:  2017-02-27       Impact factor: 1.880

Review 5.  Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.

Authors:  Arundhati Jana; Edward L Hogan; Kalipada Pahan
Journal:  J Neurol Sci       Date:  2009-01-14       Impact factor: 3.181

6.  Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.

Authors:  Takeshi Yabu; Shintaro Imamura; Michiaki Yamashita; Toshiro Okazaki
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

7.  VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Authors:  I Soo; K L Madsen; Q Tejpar; B C Sydora; R Sherbaniuk; B Cinque; L Di Marzio; M Grazia Cifone; C Desimone; R N Fedorak
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

8.  Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.

Authors:  Erik Hertervig; Ake Nilsson; Mef Nilbert; Rui-Dong Duan
Journal:  Int J Colorectal Dis       Date:  2003-03-04       Impact factor: 2.571

9.  Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis.

Authors:  Jun Wu; Gert H Hansen; Ake Nilsson; Rui-Dong Duan
Journal:  Biochem J       Date:  2005-02-15       Impact factor: 3.857

10.  Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat.

Authors:  Jan Lillienau; Yajun Cheng; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.